Pharmacology
Conference Coverage
Brain stimulation can improve prognosis following a stroke and other neurological diseases
The use of noninvasive brain stimulation is already within reach for the neurorehabilitation of stroke patients. “I am optimistic that in a few...
Conference Coverage
Antidepressants benefit some patients with osteoarthritis pain
Although some patients benefit from antidepressants for osteoarthritis pain, it’s difficult to know which patients will benefit and which will be...
News
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
The co-primary endpoints were change in IGA and EASI scores at 16 weeks, and both improved rapidly, showing statistical significance relative to...
News
Melatonin: A new way to reduce self-harm?
Melatonin may reduce the risk of self-harm by treating sleep problems related to psychiatric comorbidities, especially anxiety and depression.
News
Dupilumab moves forward as possible COPD treatment
Phase 3 data support dupilumab’s bid to become the first FDA-approved biologic for the treatment of COPD.
News
Forceps may help moms with obesity avoid cesareans
Neonatal morbidity did not differ by obesity status following forceps-attempted delivery.
News
Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows
Delgocitinib is an investigational topical pan-JAK inhibitor that inhibits activation of the JAK-STAT pathway.
News
FDA approves new formulation of Hyrimoz adalimumab biosimilar
The agency approved a higher-concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
News
Anifrolumab shows promise in refractory discoid lupus erythematosus
Anifrolumab improved symptoms and activity of DLE within 2 months in a study of eight women.
Conference Coverage
New JAK inhibitor study data confirm benefit in alopecia areata
Deuruxolitinib (CTP-543), an inhibitor of the JAK1 and JAK2 enzymes, has the potential to become the second JAK inhibitor available for the...